|
|
|
|









,****








,****
* Medical Research Council, PROMEC Unit, Tygerberg 7505, South Africa;
Toxicology and Mycotoxin Research Unit, U.S. Department of Agriculture-ARS, Athens, GA 30605;
** Division of Infectious Disease Epidemiology and Surveillance, Texas Department of Health, Austin, TX 78756;
Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA 30329;

Twin Bridges, MT 59754;

Center for Human Molecular Genetics, Department of Cell Biology & Anatomy; Munroe-Meyer Institute, Nebraska Medical Center, Omaha, NE 68198;
# Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115;
Genetics Clinic, Department of Pediatrics, Hospital General San Juan de Dios, Guatemala City, Guatemala;
*** Instituto de Nutricion de Centroamerica y Panama (INCAP/OPS), Guatemala City, Guatemala;


School of Chemistry and Biochemistry and
**** School of Biology, Georgia Institute of Technology, Atlanta, GA 30332; and


Department of Chemistry, Carleton University, Ottawa, Ontario K1S 5B6, Canada
2To whom correspondence should be addressed. E-mail: wally.marasas@mrc.ac.za or al.merrill{at}biology.gatech.edu.
Fumonisins are a family of toxic and carcinogenic mycotoxins produced by Fusarium verticillioides (formerly Fusarium moniliforme), a common fungal contaminant of maize. Fumonisins inhibit ceramide synthase, causing accumulation of bioactive intermediates of sphingolipid metabolism (sphinganine and other sphingoid bases and derivatives) as well as depletion of complex sphingolipids, which interferes with the function of some membrane proteins, including the folate-binding protein (human folate receptor
). Fumonisin causes neural tube and craniofacial defects in mouse embryos in culture. Many of these effects are prevented by supplemental folic acid. Recent studies in LMBc mice found that fumonisin exposure in utero increases the frequency of developmental defects and administration of folate or a complex sphingolipid is preventive. High incidences of neural tube defects (NTD) occur in some regions of the world where substantial consumption of fumonisins has been documented or plausibly suggested (Guatemala, South Africa, and China); furthermore, a recent study of NTD in border counties of Texas found a significant association between NTD and consumption of tortillas during the first trimester. Hence, we propose that fumonisins are potential risk factors for NTD, craniofacial anomalies, and other birth defects arising from neural crest cells because of their apparent interference with folate utilization.
KEY WORDS: fumonisins neural tube defects craniofacial abnormalities sphingolipids folate
This article has been cited by other articles:
![]() |
N. C. Zitomer, T. Mitchell, K. A. Voss, G. S. Bondy, S. T. Pruett, E. C. Garnier-Amblard, L. S. Liebeskind, H. Park, E. Wang, M. C. Sullards, et al. Ceramide Synthase Inhibition by Fumonisin B1 Causes Accumulation of 1-Deoxysphinganine: A NOVEL CATEGORY OF BIOACTIVE 1-DEOXYSPHINGOID BASES AND 1-DEOXYDIHYDROCERAMIDES BIOSYNTHESIZED BY MAMMALIAN CELL LINES AND ANIMALS J. Biol. Chem., February 20, 2009; 284(8): 4786 - 4795. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Stockmann-Juvala and K Savolainen A review of the toxic effects and mechanisms of action of fumonisin B1 Human and Experimental Toxicology, November 1, 2008; 27(11): 799 - 809. [Abstract] [PDF] |
||||
![]() |
S. T. Pruett, A. Bushnev, K. Hagedorn, M. Adiga, C. A. Haynes, M. C. Sullards, D. C. Liotta, and A. H. Merrill Jr. Thematic Review Series: Sphingolipids. Biodiversity of sphingoid bases ("sphingosines") and related amino alcohols J. Lipid Res., August 1, 2008; 49(8): 1621 - 1639. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Nguyen, R. Grajeda, P. Melgar, J. Marcinkevage, R. Flores, and R. Martorell Weekly May Be as Efficacious as Daily Folic Acid Supplementation in Improving Folate Status and Lowering Serum Homocysteine Concentrations in Guatemalan Women J. Nutr., August 1, 2008; 138(8): 1491 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Y. Gong, L. Torres-Sanchez, L. Lopez-Carrillo, J. H. Peng, A. E. Sutcliffe, K. L. White, H.-U. Humpf, P. C. Turner, and C. P. Wild Association between Tortilla Consumption and Human Urinary Fumonisin B1 Levels in a Mexican Population Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 688 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Torres, E. Palencia, L. L. de Pratdesaba, R. Grajeda, M. Fuentes, M. C. Speer, A. H. Merrill Jr., K. O'Donnell, C. W. Bacon, A. E. Glenn, et al. Estimated Fumonisin Exposure in Guatemala Is Greatest in Consumers of Lowland Maize J. Nutr., December 1, 2007; 137(12): 2723 - 2729. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-N. Chang, J.-N. Tsai, B.-H. Chen, H.-S. Huang, and T.-F. Fu Serine Hydroxymethyltransferase Isoforms Are Differentially Inhibited by Leucovorin: Characterization and Comparison of Recombinant Zebrafish Serine Hydroxymethyltransferases Drug Metab. Dispos., November 1, 2007; 35(11): 2127 - 2137. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Abdel Nour, D. Ringot, J.-L. Gueant, and A. Chango Folate receptor and human reduced folate carrier expression in HepG2 cell line exposed to fumonisin B1 and folate deficiency Carcinogenesis, November 1, 2007; 28(11): 2291 - 2297. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Brown, R. A. E. Butchko, M. Busman, and R. H. Proctor The Fusarium verticillioides FUM Gene Cluster Encodes a Zn(II)2Cys6 Protein That Affects FUM Gene Expression and Fumonisin Production Eukaryot. Cell, July 1, 2007; 6(7): 1210 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Krishnamurthy, G. Wang, J. Silva, B. G. Condie, and E. Bieberich Ceramide Regulates Atypical PKC{zeta}/{lambda}-mediated Cell Polarity in Primitive Ectoderm Cells: A NOVEL FUNCTION OF SPHINGOLIPIDS IN MORPHOGENESIS J. Biol. Chem., February 2, 2007; 282(5): 3379 - 3390. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Voss, J. Liu, S. P. Anderson, C. Dunn, J. D. Miller, J. R. Owen, R. T. Riley, C. W. Bacon, and J. C. Corton Toxic Effects of Fumonisin in Mouse Liver Are Independent of the Peroxisome Proliferator-Activated Receptor {alpha} Toxicol. Sci., January 1, 2006; 89(1): 108 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mizugishi, T. Yamashita, A. Olivera, G. F. Miller, S. Spiegel, and R. L. Proia Essential Role for Sphingosine Kinases in Neural and Vascular Development Mol. Cell. Biol., December 15, 2005; 25(24): 11113 - 11121. [Abstract] [Full Text] [PDF] |
||||